The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Bilal Siddiqui
Honoraria - Cancer Expert Now; Cardinal Health; Curio Science; DAVA Pharmaceuticals
Consulting or Advisory Role - Amgen; Bayer; Johnson and Johnson; Merck; Pfizer; Survivornet
Research Funding - Amgen (Inst); Cancer Research Institute; Conquer Cancer, the ASCO Foundation; Johnson & Johnson/Janssen (Inst); Prostate Cancer Foundation; Regeneron (Inst)
Travel, Accommodations, Expenses - Cardinal Health; Curio Science; Merck
 
Sreyashi Basu
No Relationships to Disclose
 
Sonali Jindal
No Relationships to Disclose
 
Miao Zhang
No Relationships to Disclose
 
Keyi Zhu
No Relationships to Disclose
 
Patricia Troncoso
No Relationships to Disclose
 
Sabina Sandigursky
Employment - Regeneron
Stock and Other Ownership Interests - Regeneron
Travel, Accommodations, Expenses - Regeneron
 
Elizabeth Miller
Employment - Regeneron
Stock and Other Ownership Interests - Regeneron
Patents, Royalties, Other Intellectual Property - involved in patents through employment at Regeneron
Travel, Accommodations, Expenses - Regeneron
 
Dimitris Skokos
Employment - Regeneron
 
Achim Moesta
Employment - Regeneron; Trishula Therapeutics
Stock and Other Ownership Interests - Trishula Therapeutics (Inst)
Patents, Royalties, Other Intellectual Property - Issued patent and/or pending patent application
 
Marissa Mezzancello
Employment - Regeneron
 
Frank Seebach
Employment - Regeneron
Leadership - Regeneron
Stock and Other Ownership Interests - Regeneron
 
Israel Lowy
Employment - Regeneron
Leadership - Regeneron
Stock and Other Ownership Interests - Regeneron
Patents, Royalties, Other Intellectual Property - Regeneron
 
Rebecca Tidwell
No Relationships to Disclose
 
Padmanee Sharma
Stock and Other Ownership Interests - Achelois Oncology; Achelois Oncology (I); Adaptive Biotechnologies; Adaptive Biotechnologies (I); Affini-T Therapeutics; Affini-T Therapeutics (I); Akoya Biosciences; Akoya Biosciences (I); Apricity Health; Apricity Health (I); Bectas (I); BioAtla; BioAtla (I); BioNTech; BioNTech (I); Candel Therapeutics; Candel Therapeutics (I); Catalio; Codiak Biosciences; Codiak Biosciences (I); Dragonfly Therapeutics; Dragonfly Therapeutics (I); Earli; Earli (I); Enable Medicine; Enable Medicine (I); Glympse Bio; Hummingbird; Hummingbird (I); ImaginAb; ImaginAb (I); Infinity Pharmaceuticals; InterVenn Biosciences; InterVenn Biosciences (I); JSL Health; Lava Therapeutics; Lava Therapeutics (I); Lytix Biopharma; Lytix Biopharma (I); Marker Therapeutics; Marker Therapeutics (I); Matrisome; Oncolytics; Osteologic; Osteologic Therpeutics (I); PBM Capital; PBM Capital (I); Phenomic AI; Phenomic AI (I); Polaris; Polaris (I); Sporos Bio; Time Bioventures; Trained Therapeutix Discovery; Trained Therapeutix Discovery (I); Two Bear Capital; Two Bear Capital (I)
Consulting or Advisory Role - Achelois Oncology; Achelois Oncology (I); Affini-T Therapeutics; Apricity Health; Apricity Health (I); Asher Biotherapeutics; BioAtla; BioAtla (I); C-Reveal Therapeutics; Candel Therapeutics; Candel Therapeutics (I); Carisma Therapeutics; Catalio; Codiak Biosciences; Codiak Biosciences (I); Dragonfly Therapeutics; Dragonfly Therapeutics (I); Earli; Earli (I); Enable Medicine; Enable Medicine (I); Glympse Bio; Henlius; Hummingbird; Hummingbird (I); ImaginAb; ImaginAb (I); Infinity Pharmaceuticals; InterVenn Biosciences; Lava Therapeutics; Lava Therapeutics (I); Lytix Biopharma; Lytix Biopharma (I); Marker Therapeutics; Marker Therapeutics (I); Oncolytics; PBM Capital; PBM Capital (I); Phenomic AI; Phenomic AI (I); Polaris; Polaris (I); Trained Therapeutix Discovery; Trained Therapeutix Discovery (I); Two Bear Capital; Two Bear Capital (I); Xilis
Patents, Royalties, Other Intellectual Property - Own patent licensed to Jounce; Own patents licensed to BMS, Jounce & Merck (I)
 
Sumit Subudhi
Stock and Other Ownership Interests - Apricity Health
Honoraria - Arcus Biosciences; Bristol Myers Squibb; Dendreon; Hervolution; Johnson & Johnson; Merck; Novartis
Consulting or Advisory Role - Pfizer
Research Funding - Amgen (Inst); Arcus Biosciences (Inst); Bristol-Myers Squibb (Inst); Macrogenics (Inst); Regeneron (Inst); Tarus Therapeutics (Inst)